The Mulligan Law Firm is Investigating Injury Claims: The Anti-epileptic Drug Dilantin® has Allegedly Been Linked to Stevens Johnson Syndrome (SJS)

Share Article

The Mulligan Law Firm is currently investigating injury claims involving Dilantin's possible role in the development of Stevens Johnson Syndrome (SJS). Any individual who has developed Stevens Johnson Syndrome after taking Dilantin should consult with a legal professional immediately. The Mulligan Law Firm has experienced lawyers standing by to help them.

The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Dilantin's possible role in the development of Stevens Johnson Syndrome (SJS).

For those who have developed SJS and taken Dilantin, a legal professional should be consulted immediately. Contact Eric Gruenwald, Lawyer/Attorney at (866) 529-0001, Ext. 245. The Mulligan Law Firm takes all cases on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

The FDA posted an alert on Dilantin (Phenytoin) in November of 2008: the drug is under investigation because of potential increased risk of serious skin reactions, including Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrosis (TEN).

What is Stevens Johnson Syndrome (SJS)?
Stevens Johnson Syndrome (SJS) is rare disorder where the skin and mucous membranes react severely to a medication or infection. SJS is thought to develop due to an immune system disorder, and recovery can take weeks to months, depending on the severity of the condition. Stevens Johnson Syndrome usually requires hospitalization.

Toxic epidermal necrosis (TEN) is considered to be a more virulent form of Stevens Johnson Syndrome (SJS), and many refer to both as the entity SJS/TEN.

The Three Classifications of SJS/TEN
The simplest way SJS/TEN disease severity is classified is according to body surface area; how much of the skin surface is sloughed off in the disease process.

  • Stevens Johnson Syndrome is considered a less severe form of TEN - less than 10% of the skin (body surface area) is lost.
  • Middle Level Stevens Johnson Syndrome/toxic epidermal necrolysis (SJS/TEN) - 10% - 30% detachment.
  • Toxic epidermal necrolysis - more than 30% detachment.

Anyone who has taken Dilantin and experienced any of the symptoms of Stevens Johnson Syndrome or toxic epidermal necrolysis, please contact us immediately for a free consultation.

About Dilantin
Dilantin is an anti-epileptic, anti-convulsant drug that acts to dampen the runaway brain activity that causes seizures. It is one of the oldest epilepsy medications; in 1938 a new compound, diphenylhydantoin, was a failure as a sedative but was found to have seizure-preventing properties.

Now produced by Pfizer Inc., Dilantin and its generic, Phenytoin, are the most popular drugs in the United States for treatment of partial and secondarily generalized seizures.

Consult with your physician before you stop taking any medications, including Dilantin.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eric Gruenwald
The Mulligan Law Firm
(866) 529-0001 ext. 245
Email >
Visit website